PATENT CLAIM ANALYSIS

Application Number: 15875657
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "170000"]

Abstract:
A hormone modulator for causing cellular apoptosis in triple-negative breast cancer cells. The hormone modulator includes at least one of Δ5-androsten-3β,17β-diol and Δ5-androsten-3β,7β,17β-triol and estradiol.

Claim (Index 6):
A method of preparing the hormone modulator of  claim 1 , the method comprising:\n preparing a first solution of \u03945-androsten-3\u03b2,7\u03b2,17\u03b2-triol; preparing a second solution of estradiol; and combining the first and second solutions.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.17391
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14798208', '14774163', '10390032', '14293632', '14645578']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7008060594564511
- 35 USC 102 Novelty (BERT): 0.5059111492916152
- Combined Prediction Score: 0.6813165684399676
- Mean Citation Score: 135.915908
- Max Citation Score: 141.99796
- Similarity Product: 73.98295545681

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test